A Bivalent Activatable Fluorescent Probe for Screening and Intravital Imaging of Chemotherapy-Induced Cancer Cell

Nicole D Barth1, Lorena Mendive-Tapia1, Ramon Subiros-Funosas1

  • 1Centre for Inflammation Research, The University of Edinburgh, UK.

Insights

Researchers developed Apotracker Red, a novel fluorescent probe for real-time detection of cancer cell death. This tool aids in evaluating anticancer drugs in vitro and imaging chemotherapy-induced apoptosis in vivo.

Area of Science:

  • Oncology
  • Biomedical Imaging
  • Molecular Biology

Background:

  • Accurate detection of apoptotic cells is crucial for cancer research and drug development.
  • Existing fluorescent probes often face limitations with tissue autofluorescence in live imaging.
  • Intravital optical imaging requires reliable probes for in situ functional readouts.

Purpose of the Study:

  • To design and optimize a fluorogenic probe for real-time apoptosis detection.
  • To develop a reliable tool for characterizing anticancer therapeutic effects.
  • To enable in vivo imaging of chemotherapy-induced apoptosis.

Main Methods:

  • Design and synthesis of the fluorogenic probe Apotracker Red.
  • Optimization of probe properties including fluorescence, selectivity, and stability.
  • In vitro and in vivo evaluation in breast cancer models.

Main Results:

  • Apotracker Red exhibits strong fluorogenic behavior and high selectivity.
  • The probe demonstrates excellent stability for reliable optical reporting.
  • Successful real-time detection of cancer cell death and chemotherapy-induced apoptosis in vivo.

Conclusions:

  • Apotracker Red is an effective tool for real-time apoptosis detection.
  • The probe facilitates characterization of anticancer drug effects in vitro and in vivo.
  • Apotracker Red offers a reliable method for optical imaging in cancer research.

Related Concept Videos